Pub Date : 2024-05-01DOI: 10.1016/j.endinu.2024.02.005
Joana Nicolau, Andrea Romano, Irene Rodríguez, Pilar Sanchís, María Puga, Lluís Masmiquel
Introduction
The global increase in the prevalence rates of overweight or obesity has also affected patients with type 1 diabetes (T1D), where this disease had traditionally been associated with a lean phenotype. On the other hand, the effect of obesity on new glycemic control metrics obtained from continuous glucose monitoring (CGM) in T1D is poorly understood. We wanted to assess whether there is any relationship between BMI (body mass index) and the different CGM metrics or HbA1c.
Methods
Two hundred and twenty-five patients with T1D (47.1% ♀, mean age 42.9 ± 14.7 years) with a CGM for a minimum of 6 months were analysed by downloading their CGM and collecting clinical and anthropometric variables.
Results
35.1% (79/225) of the T1D patients had overweight and 17.3% (39/225) lived with obesity, while the remaining 47.6% had a normal weight. A negative correlation was found between GMI (glucose management indicator) and BMI (−0.2; p = 0.008) and HbA1c (−0.2; p = 0.01). In contrast, a positive correlation was observed between the total dose of insulin and the BMI (0.3; p < 0.0001). No significant correlations were found between BMI and other CGM metrics.
Conclusions
Overweight or obesity do not imply worse glycemic control in patients with T1D or less use of CGM. Possibly, and in order to achieve a good glycemic control, more units of insulin are necessary in these patients which, in turn, makes weight control more difficult.
{"title":"Influence of obesity on blood glucose control using continuous glucose monitoring data among patients with type 1 diabetes","authors":"Joana Nicolau, Andrea Romano, Irene Rodríguez, Pilar Sanchís, María Puga, Lluís Masmiquel","doi":"10.1016/j.endinu.2024.02.005","DOIUrl":"10.1016/j.endinu.2024.02.005","url":null,"abstract":"<div><h3>Introduction</h3><p>The global increase in the prevalence rates of overweight or obesity has also affected patients with type 1 diabetes (T1D), where this disease had traditionally been associated with a lean phenotype. On the other hand, the effect of obesity on new glycemic control metrics obtained from continuous glucose monitoring (CGM) in T1D is poorly understood. We wanted to assess whether there is any relationship between BMI (body mass index) and the different CGM metrics or HbA1c.</p></div><div><h3>Methods</h3><p>Two hundred and twenty-five patients with T1D (47.1% ♀, mean age 42.9<!--> <!-->±<!--> <!-->14.7 years) with a CGM for a minimum of 6 months were analysed by downloading their CGM and collecting clinical and anthropometric variables.</p></div><div><h3>Results</h3><p>35.1% (79/225) of the T1D patients had overweight and 17.3% (39/225) lived with obesity, while the remaining 47.6% had a normal weight. A negative correlation was found between GMI (glucose management indicator) and BMI (−0.2; <em>p</em> <!-->=<!--> <!-->0.008) and HbA1c (−0.2; <em>p</em> <!-->=<!--> <!-->0.01). In contrast, a positive correlation was observed between the total dose of insulin and the BMI (0.3; <em>p</em> <!--><<!--> <!-->0.0001). No significant correlations were found between BMI and other CGM metrics.</p></div><div><h3>Conclusions</h3><p>Overweight or obesity do not imply worse glycemic control in patients with T1D or less use of CGM. Possibly, and in order to achieve a good glycemic control, more units of insulin are necessary in these patients which, in turn, makes weight control more difficult.</p></div>","PeriodicalId":37725,"journal":{"name":"Endocrinologia, Diabetes y Nutricion","volume":"71 5","pages":"Pages 202-207"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140773740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-01DOI: 10.1016/j.endinu.2024.02.004
Diego Valero Garzón , Santiago Forero Saldarriaga , Ana Milena Robayo Batancourt , José David Puerta Rojas , Valentina Aranguren Pardo , Lina Paola Fajardo Latorre , Milciades Ibañez Pinilla
Objective
To determine the risk factors for hypoglycaemia in patients with diabetes on general hospital wards based on a systematic review of the literature since 2013 and meta-analysis.
Methods
Systematic review of the literature focused on the conceptual and methodological aspects of the PRISMA Declaration. The search carried out in Pub Med, Web of Science, Medline, Scielo, Lilacs, OVID, grey literature and Google Academic focused on risk factors for hypoglycaemia in patients with diabetes on general hospital wards. The CASPe (Critical Appraisal Skills Programme Spanish) tool was applied for quality control.
Results
From 805 references, 70 potentially eligible articles were identified for review of abstracts and full text. Finally, according to inclusion and exclusion criteria, seven studies with 554,601 patients of Asian, European and North American ethnicity were selected.
A meta-analysis performed using the random effects model found an association between the presence of hypoglycaemia and: the use of insulin (OR 2.89 [95% CI: 1.8-4.5]); the use of long-acting insulin (OR 2.27 [95% CI: 1.8-2.8]) or fast-acting insulin (OR 1.4 [95% CI: 1.18-1.85]); nasogastric tube feeding (OR 1.75 [95% CI: 1.33-2.3]); chronic kidney disease (OR 1.65 [95% CI: 1.14-2.38]); congestive heart failure (OR 1.36 [95% CI: 1.10-1.68]); and elevated levels of glycosylated haemoglobin (OR 1.59 [95% CI: 1.32-1.91]).
Conclusion
The factors associated with the risk of hypoglycaemia in non-critically ill hospitalised patients with type 2 diabetes were: use of any insulin; nasogastric tube feeding; elevated glycosylated haemoglobin levels; history of congestive heart failure; and chronic kidney disease.
{"title":"Factores de riesgo de hipoglicemia en pacientes diabéticos hospitalizados no críticos: revisión sistemática de la literatura y metaanálisis","authors":"Diego Valero Garzón , Santiago Forero Saldarriaga , Ana Milena Robayo Batancourt , José David Puerta Rojas , Valentina Aranguren Pardo , Lina Paola Fajardo Latorre , Milciades Ibañez Pinilla","doi":"10.1016/j.endinu.2024.02.004","DOIUrl":"https://doi.org/10.1016/j.endinu.2024.02.004","url":null,"abstract":"<div><h3>Objective</h3><p>To determine the risk factors for hypoglycaemia in patients with diabetes on general hospital wards based on a systematic review of the literature since 2013 and meta-analysis.</p></div><div><h3>Methods</h3><p>Systematic review of the literature focused on the conceptual and methodological aspects of the PRISMA Declaration. The search carried out in Pub Med, Web of Science, Medline, Scielo, Lilacs, OVID, grey literature and Google Academic focused on risk factors for hypoglycaemia in patients with diabetes on general hospital wards. The CASPe (Critical Appraisal Skills Programme Spanish) tool was applied for quality control.</p></div><div><h3>Results</h3><p>From 805 references, 70 potentially eligible articles were identified for review of abstracts and full text. Finally, according to inclusion and exclusion criteria, seven studies with 554,601 patients of Asian, European and North American ethnicity were selected.</p><p>A meta-analysis performed using the random effects model found an association between the presence of hypoglycaemia and: the use of insulin (OR 2.89 [95% CI: 1.8-4.5]); the use of long-acting insulin (OR 2.27 [95% CI: 1.8-2.8]) or fast-acting insulin (OR 1.4 [95% CI: 1.18-1.85]); nasogastric tube feeding (OR 1.75 [95% CI: 1.33-2.3]); chronic kidney disease (OR 1.65 [95% CI: 1.14-2.38]); congestive heart failure (OR 1.36 [95% CI: 1.10-1.68]); and elevated levels of glycosylated haemoglobin (OR 1.59 [95% CI: 1.32-1.91]).</p></div><div><h3>Conclusion</h3><p>The factors associated with the risk of hypoglycaemia in non-critically ill hospitalised patients with type 2 diabetes were: use of any insulin; nasogastric tube feeding; elevated glycosylated haemoglobin levels; history of congestive heart failure; and chronic kidney disease.</p></div>","PeriodicalId":37725,"journal":{"name":"Endocrinologia, Diabetes y Nutricion","volume":"71 5","pages":"Pages 194-201"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140879811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-01DOI: 10.1016/j.endinu.2024.02.002
Antonio Bustos-Merlo, Carlos Javier García Calvente, Antonio Rosales-Castillo
{"title":"La importancia de la técnica MLPA en el diagnóstico de la neoplasia endocrina múltiple tipo 1","authors":"Antonio Bustos-Merlo, Carlos Javier García Calvente, Antonio Rosales-Castillo","doi":"10.1016/j.endinu.2024.02.002","DOIUrl":"10.1016/j.endinu.2024.02.002","url":null,"abstract":"","PeriodicalId":37725,"journal":{"name":"Endocrinologia, Diabetes y Nutricion","volume":"71 5","pages":"Pages 223-225"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140403668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-01DOI: 10.1016/j.endinu.2024.03.004
Inês Cosme , Ema Nobre , Maria João Bugalho
Introduction
It is suggested to wait at least 3 months to repeat a fine needle aspiration cytology (FNAC) to avoid possible inflammatory cytological changes induced by a previous procedure. This study evaluated the influence of the interval between 2 FNACs in a cohort with a previous non-diagnostic (ND) FNAC. We analysed the occurrence of ND or atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS) results in the second FNAC, based on the intervals between procedures.
Patients and methods
Retrospective study (2017–2020) including thyroid nodules with a ND result, subjected to another FNAC. Demographic, clinical and echographic data, interval between FNACs and their results were collected. We considered the intervals: ≤/>3 months and ≤/>6 months. Second FNAC results were classified as ND, AUS/FLUS or diagnostic (including the other Bethesda categories).
Results
Included 190 nodules (190 patients – 82.1% women, mean age 60 ± 13.7 years) with a first ND FNAC. The second FNAC results were: ND in 63 cases, AUS/FLUS in 9 and diagnostic in 118 cases. There were no statistical differences in FNAC results performed ≤ 3 months (13 ND, 2 AUS/FLUS, 19 diagnostic) vs >3 months (50 ND, 7 AUS/FLUS, 99 diagnostic; p = 0.71). Similarly, there were no statistical differences considering a longer time interval: ≤6 months (32 ND, 3 AUS/FLUS, 59 diagnostic) vs >6 months (31 ND, 6 AUS/FLUS, 59 diagnostic; p = 0.61).
Conclusions
Time interval between FNACs was not relevant to the final cytological result. Early FNAC repetition did not increase the cases of ND or AUS/FLUS.
{"title":"Repetition of thyroid fine-needle aspiration cytology after an initial nondiagnostic result: Is there an optimal timing?","authors":"Inês Cosme , Ema Nobre , Maria João Bugalho","doi":"10.1016/j.endinu.2024.03.004","DOIUrl":"10.1016/j.endinu.2024.03.004","url":null,"abstract":"<div><h3>Introduction</h3><p>It is suggested to wait at least 3 months to repeat a fine needle aspiration cytology (FNAC) to avoid possible inflammatory cytological changes induced by a previous procedure. This study evaluated the influence of the interval between 2 FNACs in a cohort with a previous non-diagnostic (ND) FNAC. We analysed the occurrence of ND or atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS) results in the second FNAC, based on the intervals between procedures.</p></div><div><h3>Patients and methods</h3><p>Retrospective study (2017–2020) including thyroid nodules with a ND result, subjected to another FNAC. Demographic, clinical and echographic data, interval between FNACs and their results were collected. We considered the intervals: ≤/>3 months and ≤/>6 months. Second FNAC results were classified as ND, AUS/FLUS or diagnostic (including the other Bethesda categories).</p></div><div><h3>Results</h3><p>Included 190 nodules (190 patients – 82.1% women, mean age 60<!--> <!-->±<!--> <!-->13.7 years) with a first ND FNAC. The second FNAC results were: ND in 63 cases, AUS/FLUS in 9 and diagnostic in 118 cases. There were no statistical differences in FNAC results performed<!--> <!-->≤<!--> <!-->3 months (13 ND, 2 AUS/FLUS, 19 diagnostic) vs >3 months (50 ND, 7 AUS/FLUS, 99 diagnostic; <em>p</em> <!-->=<!--> <!-->0.71). Similarly, there were no statistical differences considering a longer time interval: ≤6 months (32 ND, 3 AUS/FLUS, 59 diagnostic) vs >6 months (31 ND, 6 AUS/FLUS, 59 diagnostic; <em>p</em> <!-->=<!--> <!-->0.61).</p></div><div><h3>Conclusions</h3><p>Time interval between FNACs was not relevant to the final cytological result. Early FNAC repetition did not increase the cases of ND or AUS/FLUS.</p></div>","PeriodicalId":37725,"journal":{"name":"Endocrinologia, Diabetes y Nutricion","volume":"71 5","pages":"Pages 216-220"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140774046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-01DOI: 10.1016/j.endinu.2024.02.001
Andrés Ruiz de Assín Valverde, José Joaquín Alfaro Martínez, María Carmen López García, Marina Jara Vidal, Marta Gallach Martínez, Noel Roig-Marin, Rosa Pilar Quílez Toboso, César Gonzalvo Díaz, Lourdes García Blasco, Pedro José Pinés Corrales, Cristina Lamas Oliveira, Silvia Aznar Rodríguez, Elena Parreño Caparrós, Luz María López Jiménez
Introduction
Endocrinology and Nutrition (EyN) is an outpatient and inpatient medical specialty. This study aims to understand the evolution of the activity of interdepartmental consultation (IC) carried out by EyN in hospitalization floor of a third-level hospital, comparing its evolution with other medical specialties, and comparing endocrine IC with nutritional IC.
Material and methods
Longitudinal and retrospective study which analyzes IC notes of EyN and other medical specialties between 01-01-2013 and 31-12-2022.
Results
A total of 76,093 IC notes (12,623 patients) were performed by the EyN service (average age 65.4 years; 59% male) with an average of 4.8 notes per patient. Average annual growth was 7% in notes and 4% in patients (versus 6% and 3% of all other medical services, differences statistically significant). Of all patients hospitalized for 4 or more days, EyN went from attending 7.9% (2013) to 12.3% (2022). 66% of the IC performed by EyN was for nutritional cause and 34% for other pathologies.
Conclusions
The EyN service is the one that most patients attend in hospital IC activity, with growth over the last few years greater than other medical specialties. Nutritional pathology is the main reason for IC.
导言内分泌与营养科(EyN)是一个门诊和住院医疗专科。本研究旨在了解内分泌与营养科在一家三级医院住院楼开展的科间会诊(IC)活动的演变情况,并将其与其他医学专科的演变情况进行比较,同时将内分泌科的 IC 与营养科的 IC 进行比较。材料和方法纵向和回顾性研究分析了 EyN 和其他医疗专科在 2013 年 1 月 1 日至 2022 年 12 月 31 日期间的 IC 病历。结果EyN 服务共完成 76,093 份 IC 病历(12,623 名患者)(平均年龄 65.4 岁;59% 为男性),平均每位患者 4.8 份病历。记录的平均年增长率为 7%,患者的平均年增长率为 4%(所有其他医疗服务的增长率分别为 6%和 3%,差异具有统计学意义)。在所有住院 4 天或 4 天以上的患者中,EyN 的就诊率从 7.9%(2013 年)上升到 12.3%(2022 年)。在由 EyN 实施的 IC 中,66% 是由于营养原因,34% 是由于其他病理原因。营养病理是 IC 的主要原因。
{"title":"Evolución de la actividad de interconsultas a Endocrinología y Nutrición en planta de hospitalización en un hospital de tercer nivel","authors":"Andrés Ruiz de Assín Valverde, José Joaquín Alfaro Martínez, María Carmen López García, Marina Jara Vidal, Marta Gallach Martínez, Noel Roig-Marin, Rosa Pilar Quílez Toboso, César Gonzalvo Díaz, Lourdes García Blasco, Pedro José Pinés Corrales, Cristina Lamas Oliveira, Silvia Aznar Rodríguez, Elena Parreño Caparrós, Luz María López Jiménez","doi":"10.1016/j.endinu.2024.02.001","DOIUrl":"10.1016/j.endinu.2024.02.001","url":null,"abstract":"<div><h3>Introduction</h3><p>Endocrinology and Nutrition (EyN) is an outpatient and inpatient medical specialty. This study aims to understand the evolution of the activity of interdepartmental consultation (IC) carried out by EyN in hospitalization floor of a third-level hospital, comparing its evolution with other medical specialties, and comparing endocrine IC with nutritional IC.</p></div><div><h3>Material and methods</h3><p>Longitudinal and retrospective study which analyzes IC notes of EyN and other medical specialties between 01-01-2013 and 31-12-2022.</p></div><div><h3>Results</h3><p>A total of 76,093 IC notes (12,623 patients) were performed by the EyN service (average age 65.4 years; 59% male) with an average of 4.8 notes per patient. Average annual growth was 7% in notes and 4% in patients (versus 6% and 3% of all other medical services, differences statistically significant). Of all patients hospitalized for 4 or more days, EyN went from attending 7.9% (2013) to 12.3% (2022). 66% of the IC performed by EyN was for nutritional cause and 34% for other pathologies.</p></div><div><h3>Conclusions</h3><p>The EyN service is the one that most patients attend in hospital IC activity, with growth over the last few years greater than other medical specialties. Nutritional pathology is the main reason for IC.</p></div>","PeriodicalId":37725,"journal":{"name":"Endocrinologia, Diabetes y Nutricion","volume":"71 4","pages":"Pages 163-170"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140406076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-01DOI: 10.1016/j.endinu.2024.01.007
Emilia Gómez Hoyos , Patricia Cabrera García , Marcelino Gómez Balaguer , en nombre del Grupo de Trabajo de Gónada, Identidad y Diferenciación Sexual de la Sociedad Española de Endocrinología y Nutrición (GT-GIDSEEN)
Comprehensive biopsychosocial care for people with gender incongruence (ICD-11) who are transgender or gender diverse is a complex process in which the quality of the medical transition can only be guaranteed after a multidisciplinary approach, through teams that integrate professionals with training and experience not only in medicine but also in diversity and gender identity. Based on this, the Gonad, Identity and Sexual Differentiation Working Group of the Spanish Society of Endocrinology and Nutrition has established minimum care requirements that aim to guarantee adequate health care for these people by professionals. A position paper has been produced and is available at: https://www.seen.es/portal/documentos/estandares-calidad-gidseen-2024
{"title":"Resumen ejecutivo: estándares de calidad de las unidades de atención a personas con diversidad sexual y de género","authors":"Emilia Gómez Hoyos , Patricia Cabrera García , Marcelino Gómez Balaguer , en nombre del Grupo de Trabajo de Gónada, Identidad y Diferenciación Sexual de la Sociedad Española de Endocrinología y Nutrición (GT-GIDSEEN)","doi":"10.1016/j.endinu.2024.01.007","DOIUrl":"10.1016/j.endinu.2024.01.007","url":null,"abstract":"<div><p>Comprehensive biopsychosocial care for people with gender incongruence (ICD-11) who are transgender or gender diverse is a complex process in which the quality of the medical transition can only be guaranteed after a multidisciplinary approach, through teams that integrate professionals with training and experience not only in medicine but also in diversity and gender identity. Based on this, the Gonad, Identity and Sexual Differentiation Working Group of the Spanish Society of Endocrinology and Nutrition has established minimum care requirements that aim to guarantee adequate health care for these people by professionals. A position paper has been produced and is available at: <span>https://www.seen.es/portal/documentos/estandares-calidad-gidseen-2024</span><svg><path></path></svg></p></div>","PeriodicalId":37725,"journal":{"name":"Endocrinologia, Diabetes y Nutricion","volume":"71 4","pages":"Pages 181-186"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140466292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-01DOI: 10.1016/S2530-0164(24)00097-1
{"title":"SESIÓN ORAL 8: TRATAMIENTO DE LA DIABETES MELLITUS TIPO 1 22","authors":"","doi":"10.1016/S2530-0164(24)00097-1","DOIUrl":"https://doi.org/10.1016/S2530-0164(24)00097-1","url":null,"abstract":"","PeriodicalId":37725,"journal":{"name":"Endocrinologia, Diabetes y Nutricion","volume":"71 ","pages":"Pages S22-S24"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141241892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-01DOI: 10.1016/S2530-0164(24)00110-1
{"title":"TECNOLOGÍAS APLICADAS A LA DIABETES","authors":"","doi":"10.1016/S2530-0164(24)00110-1","DOIUrl":"https://doi.org/10.1016/S2530-0164(24)00110-1","url":null,"abstract":"","PeriodicalId":37725,"journal":{"name":"Endocrinologia, Diabetes y Nutricion","volume":"71 ","pages":"Pages S106-S125"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141239031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}